Login / Signup

Polysubstance use before and during treatment with medication for opioid use disorder: Prevalence and association with treatment outcomes.

Amanda M BuntingNoa KrawczykTse-Hwei ChooMartina PavlicovaJennifer McNeelyBabak TofighiJohn RotrosenEdward NunesJoshua D Lee
Published in: Journal of substance abuse treatment (2022)
In the current study population, polysubstance use was only marginally associated with 24-week treatment outcomes.
Keyphrases
  • risk factors
  • healthcare
  • randomized controlled trial
  • emergency department
  • clinical trial
  • adverse drug
  • electronic health record